natgillin/translations-raw huggingface dataset:
The costs for the execution of the programme, estimated at EUR 30,2 million, shall be financed entirely out of contributions from France and the Netherlands, through the CEA and NRG, respectively.
Ta prispevek se obravnava kot namenski prejemek v skladu s členom 21(2) Uredbe (EU, Euratom) Evropskega parlamenta in Sveta št. 966/2012 [2].Člen 3
The breakdown of this amount is set out in Annex II.
Komisija je pristojna za upravljanje programa.
This contribution shall be considered as assigned revenue in accordance with Article 21(2) of Council Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council [2].Article 3
V ta namen uporabi storitve Skupnega raziskovalnega središča.
The Commission shall be in charge of the management of the programme.
Komisija o izvajanju programa obvešča svet guvernerjev Skupnega raziskovalnega središča.
To that end, it shall call upon the services of the Joint Research Centre.
Člen 4
The Commission shall keep the Board of Governors of the Joint Research Centre informed of the implementation of the programme.
V primeru, da NRG nizozemske nacionalne regulatorne organe (pred prijavo varnega ohranitvenega stanja) uradno obvesti o dokončni zaustavitvi HFR obveznost za izvedbo nadaljnjih plačil s strani Francije in Nizozemske preko CEA oziroma NRG preneha; prav tako se ustavi vse zahtevke za dodelitev sredstev Komisije na podlagi tega sklepa.
In the event that NRG officially notifies the definitive shutdown of the HFR to the Dutch national regulatory authority (prior to the declaration of safe conservation state), the obligations on the part of France and the Netherlands, through the CEA and NRG, respectively, to make further payments shall be suspended, as shall any calls for funds by the Commission under this Decision.
Komisija predloži končno poročilo o izvajanju tega sklepa Evropskemu parlamentu in Svetu po koncu dodatnega raziskovalnega programa HFR za obdobje 2016-2019.
The Commission shall submit a final report on the implementation of this Decision to the European Parliament and to the Council after the end of the 2016-2019 HFR supplementary research programme.
Ta sklep začne veljati na dan objave v Uradnem listu Evropske unije.
Article 6
Uporablja se od 1. januarja 2016.
This Decision shall enter into force on the date of its publication in the Official Journal of the European Union.
Člen 7
It shall apply from 1 January 2016.
Ta sklep je naslovljen na države članice.
Article 7
V Bruslju, 29. maja 2017
For the Council
Sklep Sveta 2012/709/Euratom z dne 13. novembra 2012 o sprejetju dodatnega raziskovalnega programa 2012–2015 za reaktor z visokim pretokom, ki ga bo za Evropsko skupnost za atomsko energijo izvajalo Skupno raziskovalno središče (UL L 321, 20.11.2012, str. 59).
The President
Uredba (EU, Euratom) št. 966/2012 Evropskega Parlamenta in Sveta z dne 25. oktobra 2012 o finančnih pravilih, ki se uporabljajo za splošni proračun Unije in razveljavitvi Uredbe Sveta (ES, Euratom) št. 1605/2002 (UL L 298, 26.10.2012, str.
Council Decision 2012/709/Euratom of 13 November 2012 on the adoption of the 2012-2015 High Flux Reactor supplementary research programme to be implemented by the Joint Research Centre for the European Atomic Energy Community (OJ L 321, 20.11.2012, p. 59).
1).
Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council of 25 October 2012 on the financial rules applicable to the general budget of the Union and repealing Council Regulation (EC, Euratom) No 1605/2002 (OJ L 298, 26.10.2012, p. 1).
PRILOGA I
ANNEX I
ZNANSTVENI IN TEHNIČNI CILJI
SCIENTIFIC AND TECHNICAL OBJECTIVES
Glavna cilja dodatnega raziskovalnega programa sta:
The main objectives of the supplementary research programme are the following:
zagotoviti varno in zanesljivo obratovanje HFR, da se zagotovi razpoložljivost nevtronskega fluksa v poskusne namene;
To ensure the safe and reliable operation of the HFR, in order to guarantee the availability of the neutron flux for experimental purposes.
omogočiti raziskovalnim inštitutom iz različnih znanstvenih področij učinkovito rabo HFR: izboljševanje varnosti jedrskih reaktorjev; zdravja (vključno z razvojem medicinskih izotopov); jedrske fuzije; temeljne znanosti; usposabljanja in ravnanja z odpadki (vključno z varnostnim obnašanjem jedrskega goriva za reaktorske sisteme, ki so v interesu Evrope).
To allow the efficient use of the HFR by research institutes in a broad range of research areas: improvement of safety of nuclear reactors; health (including the development of medical isotopes); nuclear fusion; basic science; training; and waste management (including the safety behaviour of nuclear fuels for reactor systems of interest to Europe).
PRILOGA II
ANNEX II
RAZČLENITEV PRISPEVKOV
BREAKDOWN OF THE CONTRIBUTIONS
Prispevke za dodatni raziskovalni program bosta zagotovili Nizozemska in Francija.
The contributions to the supplementary research programme come from The Netherlands and France.
Razčlenitev navedenih prispevkov:
The breakdown of those contributions is as follows:
Francija: 1,2 milijona EUR
France: EUR 1,2 million
Nizozemska: 29 milijonov EUR
The Netherlands: EUR 29 million
skupaj: 30,2 milijona EUR.
Total: EUR 30,2 million.
Navedeni prispevki se vplačajo v splošni proračun Evropskih unije in se dodelijo temu programu.
Those contributions shall be made to the general budget of the European Union and shall be assigned to this programme.
Z delom prispevkov iz tega dodatnega programa se lahko krijejo tudi odhodki, nastali zaradi delovanja HFR v letu 2016, in sicer v skladu z delovnim programom, o katerem se dogovorijo države članice, ki zagotovijo prispevke, in Komisija.
Part of the contributions under this supplementary programme may also cover expenditure made to the operation of the HFR during the year 2016 in accordance with the work programme to be agreed among the contributing Member States and the Commission.
Ti prispevki so fiksni in nespremenljivi, kar zadeva variacije stroškov delovanja, vzdrževanja in razgradnje.
Those contributions are firm and not revisable as regards variations related to operational, maintenance and decommissioning costs.
Da bi se zagotovila neprekinjenost dodatnih raziskovalnih programov, bi se moral ta sklep začeti uporabljati od 1. januarja 2016.
In order to ensure continuity between supplementary research programmes, this Decision should apply from 1 January 2016.
Dovoliti bi bilo treba, da se z delom prispevkov za obdobje 2016-2019 za dodatni program HFR, pokrije izdatke, nastale v letu 2016.
Commission Implementing Decision (EU) 2017/957
Izvedbeni sklep Komisije (EU) 2017/957
of 6 June 2017
z dne 6. junija 2017
terminating the anti-dumping proceeding concerning imports of purified terephthalic acid and its salts originating in the Republic of Korea
o zaključku protidampinškega postopka v zvezi z uvozom prečiščene tereftalne kisline in njenih soli s poreklom iz Republike Koreje
On 3 August 2016, the European Commission (‘the Commission’) initiated an anti-dumping investigation with regard to imports into the Union of purified terephthalic acid (‘PTA’) and its salts originating in the Republic of Korea (‘the country concerned’) on the basis of Article 5 of Regulation (EU) 2016/1036 (‘the basic Regulation’).
Evropska komisija („Komisija“) je 3. avgusta 2016 na podlagi člena 5 Uredbe (EU) 2016/1036 („osnovna uredba“) začela protidampinško preiskavo v zvezi z uvozom prečiščene tereftalne kisline („PTA“) in njenih soli s poreklom iz Republike Koreje („zadevna država“) v Unijo.
The Commission initiated the investigation following a complaint lodged on 20 June 2016 by BP Aromatics Limited NV, Artland PTA SA and Indorama Ventures Quimica S.L.U.
Komisija je začela preiskavo, potem ko so družbe BP Aromatics Limited NV, Artland PTA SA in Indorama Ventures Quimica S.L.U.
(‘the complainants’), representing more than 25 % of the total Union production of purified terephthalic acid and its salts.
(„pritožniki“), ki predstavljajo več kot 25 % celotne proizvodnje prečiščene tereftalne kisline in njenih soli v Uniji, 20. junija 2016 vložile pritožbo.
In the Notice of Initiation, the Commission invited interested parties to contact it in order to participate in the investigation.
Komisija je v obvestilu o začetku pozvala zainteresirane strani, da se ji javijo, če želijo sodelovati v preiskavi.
In addition, the Commission specifically informed the complainants, other known Union producers, the known exporting producers, the South Korean authorities, known importers and users about the initiation of the investigation and invited them to participate.
Poleg tega je Komisija izrecno obvestila pritožnike, druge znane proizvajalce Unije, znane proizvajalce izvoznike, korejske organe, znane uvoznike in uporabnike o začetku preiskave ter jih povabila k sodelovanju.
In its Notice of Initiation, the Commission stated that it might sample the interested parties in accordance with Article 17 of the basic Regulation.
Komisija je v obvestilu o začetku navedla, da bo morda izvedla vzorčenje zainteresiranih strani v skladu s členom 17 osnovne uredbe.
To decide whether sampling was necessary and, if so, to select a sample, the Commission asked all exporting producers in the Republic of Korea to provide the information specified in the Notice of Initiation.
Komisija je vse proizvajalce izvoznike v Republiki Koreji pozvala, naj predložijo informacije, določene v obvestilu o začetku, da bi se lahko odločila, ali je vzorčenje potrebno, in da bi lahko v tem primeru izbrala vzorec.
In addition, the Commission asked the Mission of the Republic of Korea to the European Union to identify and/or contact other exporting producers, if any, that could be interested in participating in the investigation.
Poleg tega je misijo Republike Koreje pri Evropski uniji pozvala, naj opredeli morebitne druge proizvajalce izvoznike, ki bi želeli sodelovati v preiskavi, in/ali stopi v stik z njimi.
Five exporting producers in the country concerned provided the requested information and agreed to be included in the sample.
Pet proizvajalcev izvoznikov iz zadevne države je zagotovilo zahtevane informacije in se strinjalo z vključitvijo v vzorec.
No objections to the proposed sample were made.
Nihče ni nasprotoval predlaganemu vzorcu.
In its Notice of Initiation, the Commission stated that it would send the questionnaire to all the six known producers of the product concerned.
Komisija je v obvestilu o začetku navedla, da bo poslala vprašalnik vsem šestim znanim proizvajalcem zadevnega izdelka.
The Commission sent questionnaires to the three sampled exporting producers, all six Union producers, nine known users and two known importers.
Komisija je poslala vprašalnike trem vzorčenim proizvajalcem izvoznikom, vsem šestim proizvajalcem Unije, devetim znanim uporabnikom in dvema znanima uvoznikoma.
Questionnaire replies were received from the three sampled exporting producers, all six Union producers, twelve users and two importers.
Prejela je izpolnjene vprašalnike treh vzorčenih proizvajalcev izvoznikov, vseh šestih proizvajalcev Unije, dvanajstih uporabnikov in dveh uvoznikov.
Exporting producers in the Republic of Korea
proizvajalci izvozniki v Koreji:
Ltd, Seoul, Republic of Korea,
Ltd, Seoul, Republika Koreja,
Artlant PTA SA, Sines, Portugal,
Artlant PTA SA, Sines, Portugalska,
Indorama Ventures Quimica S.L.U., San Roque, Spain,
Indorama Ventures Quimica S.L.U., San Roque, Španija,
PKN Orlen SA, Płock, Poland,
PKN Orlen SA, Płock, Poljska,
The investigation of dumping and injury covered the period from 1 July 2015 to 30 June 2016 (‘the investigation period’).
Preiskava dampinga in škode je zajela obdobje od 1. julija 2015 do 30. junija 2016 („obdobje preiskave“).
The examination of trends relevant for the assessment of injury covered the period from 1 January 2013 to the end of the investigation period (‘the period considered’).
Proučevanje gibanj, pomembnih za oceno škode, je zajelo obdobje od 1. januarja 2013 do konca obdobja preiskave („obravnavano obdobje“).
The product concerned is terephthalic acid of a purity by weight of 99,5 % or more and its salts originating in the Republic of Korea currently falling within CN code ex29173600 (TARIC code 2917360010) (‘the product concerned’).
Zadevni izdelek je tereftalna kislina s čistočo najmanj 99,5 mas. % in njene soli s poreklom iz Republike Koreje, ki se trenutno uvrščajo pod oznako KN ex29173600 (oznaka TARIC 2917360010) („zadevni izdelek“).
The product concerned is mainly used as a raw material to synthetise polymers used, for instance, in the production of polyester textile fibres and poly (ethylene terephthalate) (PET) bottles.
Zadevni izdelek se uporablja predvsem kot surovina za sintezo polimerov, ki se uporabljajo na primer pri proizvodnji poliestrskih tekstilnih vlaken in plastenk iz polietilen tereftalata (PET).
the product produced and sold on the domestic market of country concerned, and
izdelek, ki se proizvaja in prodaja na domačem trgu zadevne države, ter
The product scope defined in recital 15 above includes variants of PTA which in addition to the purest variation of PTA (‘purest PTA’) include also the so called qualified terephthalic acid (‘QTA’) and medium quality terephthalic acid (‘MTA’).
Obseg izdelka, opredeljen v uvodni izjavi 15, vključuje različice PTA, ki poleg najčistejše različice PTA („najčistejša PTA“) zajemajo tudi tako imenovano kvalificirano tereftalno kislino („QTA“) in tereftalno kislino srednje kakovosti („MTA“).
The variants can be distinguished essentially by the levels of purity.
Različice se lahko razlikujejo predvsem po stopnjah čistoče.
MTA and QTA have higher levels of impurities than the purest PTA.
MTA in QTA imata višjo vsebnost nečistoč od najčistejše PTA.
In any event, the level of impurities in each of these variants does not exceed 0,5 % and therefore they are all included in the product definition set out in recital 15.
V vsakem primeru stopnja nečistoč v nobeni od teh različic ne presega 0,5 %, zato so vse vključene v opredelitev izdelka iz uvodne izjave 15.
Several interested parties claimed that QTA should be excluded from the scope of the product under investigation.
Več zainteresiranih strani je trdilo, da bi bilo treba QTA izključiti iz obsega izdelka v preiskavi.
According to these parties the physical and chemical characteristics of QTA are different from those of the purest PTA and these differences lead to different uses.
Po mnenju teh strani se fizikalne in kemične lastnosti QTA razlikujejo od lastnosti najčistejše PTA, zaradi teh razlik pa se tudi različno uporabljata.
They also claimed that the processes for the production and the use of QTA are different from those of the purest PTA and that the production cost and selling price of QTA are lower than those of the purest PTA.
Trdile so tudi, da se postopki za proizvodnjo in uporabo QTA razlikujejo od postopkov pri najčistejši PTA ter da so proizvodni stroški in prodajna cena QTA nižji od proizvodnih stroškov in prodajne cene najčistejše PTA.
While the purest PTA contains up to 0,01 % of impurities, QTA may contain up to 0,2 % impurities and there is also some difference in the kind of impurities contained.
Medtem ko najčistejša PTA vsebuje do 0,01 % nečistoč, lahko QTA vsebuje do 0,2 % nečistoč, poleg tega pa obstaja tudi nekaj razlik glede vrste nečistoč.
However, regardless of this difference in impurities, the chemical formula of all the variants of PTA is the same.
Ne glede na to razliko v nečistočah je kemijska formula vseh različic PTA enaka.
Therefore, the Commission considered that the relatively small difference in impurities does not alter the fact that the basic chemical and physical characteristics of all the variants of PTA are the same and consequently it would not as such justify excluding QTA from the scope of the product under investigation.
Komisija je zato menila, da razmeroma majhna razlika v nečistočah ne spreminja dejstva, da so osnovne kemijske in fizikalne lastnosti vseh različic PTA enake in zato kot take ne upravičujejo izključitve QTA iz obsega izdelka v preiskavi.
The same interested parties also claimed that QTA and the purest PTA have different uses.
Iste zainteresirane strani so trdile tudi, da se najčistejša PTA in QTA različno uporabljata.
The Commission found that the differences were not significant in order to exclude QTA from the scope of the product under investigation.
Komisija je ugotovila, da te razlike niso dovolj velike, da bi se QTA izključila iz obsega izdelka v preiskavi.
The same interested parties also claimed that the QTA and purest PTA are produced by different production processes, namely that production techniques to produce the purest PTA primarily focus on oxidation reaction, refining and reduction reaction, which belongs to a two-step production technique whereas QTA's production technique mainly focuses on precise oxidation reaction and refining, which belongs to a one-step production technique.
Iste zainteresirane strani so trdile tudi, da se QTA in najčistejša PTA pridobivata z različnimi proizvodnimi postopki, in sicer se proizvodne tehnike za proizvodnjo najčistejše PTA osredotočajo predvsem na oksidacijo, rafiniranje in redukcijo, kar spada med dvostopenjske proizvodne tehnike, tehnika proizvodnje QTA pa se osredotoča predvsem na natančno oksidacijo in rafiniranje, kar spada med enostopenjske proizvodne tehnike.
The Commission found that both production processes use the same raw materials and processes and are for most of their parts similar.
Komisija je ugotovila, da se pri obeh proizvodnih postopkih uporabljajo iste surovine in tehnike ter da sta postopka pri večini korakov podobna.
The same interested parties finally claimed that due to the difference between the abovementioned one-step and two-step techniques, the production cost of QTA is between 18 and 36 EUR/MT cheaper than that of the purest PTA.
Iste zainteresirane strani so nazadnje trdile, da so zaradi razlik med zgoraj navedenima enostopenjsko in dvostopenjsko tehniko proizvodni stroški QTA, ki znašajo od 18 do 36 EUR/tono, nižji od proizvodnih stroškov najčistejše PTA.
The investigation found that the difference in the production cost was not significant.
V preiskavi je bilo ugotovljeno, da razlika v proizvodnih stroških ni velika.
In any event, differences in the cost of production as such are not relevant in order to define the product scope but rather similar technical, chemical and physical characteristics and basic uses.
V vsakem primeru pa za opredelitev obsega izdelka niso pomembne razlike v proizvodnih stroških kot take, temveč podobne tehnične, kemične in fizikalne lastnosti ter osnovna uporaba.
After the disclosure one interested party reiterated its claims that QTA should be excluded from the scope of the product under investigation due to the differences in composition and content of impurities, differences in production process and production cost and uses.
Po razkritju je ena zainteresirana stran ponovila svojo trditev, da bi bilo treba QTA izključiti iz obsega izdelka v preiskavi zaradi razlik v sestavi in vsebnosti nečistoč, razlik v proizvodnem postopku ter proizvodnih stroškov in uporabe.
The Commission however considered that these differences are relatively small and do not alter the conclusion that the technical, chemical and physical characteristics and basic uses of both QTA and the purest PTA are essentially the same.
Vendar je Komisija menila, da so te razlike sorazmerno majhne in ne spremenijo sklepa, da so tehnične, kemične in fizikalne lastnosti ter osnovne uporabe tako QTA kot najčistejše PTA dejansko enake.
For the reasons above, the claims to exclude QTA from the scope of the product scope were rejected.
Iz zgoraj navedenih razlogov so bile trditve o izključitvi QTA iz obsega izdelka zavrnjene.
The Commission first examined whether the total volume of domestic sales for each sampled exporting producer was representative, in accordance with Article 2(2) of the basic Regulation.
Komisija je v skladu s členom 2(2) osnovne uredbe najprej proučila, ali je bil celotni obseg domače prodaje za vsakega vzorčenega proizvajalca izvoznika reprezentativen.
On this basis, the total sales by each sampled exporting producer of the like product on the domestic market were representative.
Na podlagi tega je bila skupna prodaja vsakega vzorčenega proizvajalca izvoznika podobnega izdelka na domačem trgu reprezentativna.
The Commission then examined whether the domestic sales by each sampled exporting producer on its domestic market were representative, in accordance with Article 2(2) of the basic Regulation.
Komisija je nato v skladu s členom 2(2) osnovne uredbe proučila, ali je bila domača prodaja vsakega vzorčenega proizvajalca izvoznika na njegovem domačem trgu reprezentativna.
The domestic sales of a product type are representative if the total volume of domestic sales to independent customers during the investigation period represents at least 5 % of the total volume of export sales to the Union.
Domača prodaja vrste izdelka je reprezentativna, če celotni obseg domače prodaje neodvisnim strankam v obdobju preiskave predstavlja vsaj 5 % celotnega obsega izvoza v Unijo.
The Commission established that for each sampled exporting producer the total volume of domestic sales represented at least 5 % of the total volume of export sales to the Union.
Komisija je ugotovila, da je za vsakega vzorčenega proizvajalca izvoznika celoten obseg domače prodaje predstavljal vsaj 5 % celotnega obsega izvoza v Unijo.
The Commission next defined the proportion of profitable sales to independent customers on the domestic market during the investigation period in order to decide whether to use actual domestic sales for the calculation of the normal value, in accordance with Article 2(4) of the basic Regulation.
Komisija je nato v skladu s členom 2(4) osnovne uredbe opredelila delež dobičkonosne prodaje neodvisnim strankam na domačem trgu v obdobju preiskave, da bi se lahko odločila, ali bo za izračun normalne vrednosti uporabila dejansko domačo prodajo.
The normal value is based on the actual domestic price, irrespective of whether those sales are profitable or not, if:
Normalna vrednost temelji na dejanski domači ceni ne glede na to, ali je bila ta prodaja dobičkonosna ali ne:
the sales volume, sold at a net sales price equal to or above the calculated cost of production, represented more than 80 % of the total sales volume; and
če je obseg prodaje, prodane po neto prodajni ceni, enaki izračunanim proizvodnim stroškom ali višji od njih, predstavljal več kot 80 % celotnega obsega prodaje ter
the weighted average sales price is equal to or higher than the unit cost of production.
če je tehtana povprečna prodajna cena enaka proizvodnim stroškom na enoto ali višja od njih.
In this case, the normal value was the weighted average of the prices of all domestic sales during the IP.
V tem primeru je bila normalna vrednost tehtano povprečje cen vse domače prodaje v obdobju preiskave.
For one of the exporting producers the conditions mentioned in recital 31 were met and the volume of profitable sales of the like product represented more than 80 % of the total domestic sales volume of the like product.
Za enega od proizvajalcev izvoznikov so bili izpolnjeni pogoji, navedeni v uvodni izjavi 31, in obseg dobičkonosne prodaje podobnega izdelka je predstavljal več kot 80 % celotnega obsega domače prodaje podobnega izdelka.
For this exporting producer the normal value was based on the actual domestic price, calculated as a weighted average of all domestic sales.
Za tega proizvajalca izvoznika je bila normalna vrednost osnovana na dejanski domači ceni, izračunani kot tehtano povprečje celotne domače prodaje.
The normal value was the actual domestic price of only the profitable domestic sales of the product types during the IP, if:
Normalna vrednost je bila dejanska domača cena izključno dobičkonosne domače prodaje teh vrst izdelka v obdobju preiskave:
the volume of profitable sales represents 80 % or less of the total sales volume; or
če obseg dobičkonosne prodaje predstavlja 80 % ali manj celotnega obsega prodaje ali